Schedule 13G ownership disclosure
UNICYCIVE THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 90466Y103
Event date: 2024-12-31
- Filing-level shares
- 5,000,000.00
- Percent of class
- 4.82%
- Walleye Capital LLC
Shares: 5,000,000.00 · Class: 4.82%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-000549
- Form type
- SCHEDULE 13G/A
- Filer
- Unicycive Therapeutics, Inc.
- CIK
- CIK 1766140
- Filed
- Feb 06, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership